181 related articles for article (PubMed ID: 23623867)
1. Modulation of the peroxiredoxin system by cytokines in insulin-producing RINm5F cells: down-regulation of PRDX6 increases susceptibility of beta cells to oxidative stress.
Paula FM; Ferreira SM; Boschero AC; Souza KL
Mol Cell Endocrinol; 2013 Jul; 374(1-2):56-64. PubMed ID: 23623867
[TBL] [Abstract][Full Text] [Related]
2. Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells.
Souza KL; Gurgul-Convey E; Elsner M; Lenzen S
J Endocrinol; 2008 Apr; 197(1):139-50. PubMed ID: 18372240
[TBL] [Abstract][Full Text] [Related]
3. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
Darville MI; Eizirik DL
Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
[TBL] [Abstract][Full Text] [Related]
4. [Study on the molecular expression and regulation of toll pathway in HT-29 cells].
Chen X; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):581-5. PubMed ID: 20848773
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta stimulation of c-Jun NH(2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction.
Major CD; Wolf BA
Diabetes; 2001 Dec; 50(12):2721-8. PubMed ID: 11723054
[TBL] [Abstract][Full Text] [Related]
6. Differential usage of NF-κB activating signals by IL-1β and TNF-α in pancreatic beta cells.
Ortis F; Miani M; Colli ML; Cunha DA; Gurzov EN; Allagnat F; Chariot A; Eizirik DL
FEBS Lett; 2012 Apr; 586(7):984-9. PubMed ID: 22569251
[TBL] [Abstract][Full Text] [Related]
7. Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant Mechanisms.
Melhem H; Spalinger MR; Cosin-Roger J; Atrott K; Lang S; Wojtal KA; Vavricka SR; Rogler G; Frey-Wagner I
J Crohns Colitis; 2017 Jul; 11(7):871-884. PubMed ID: 28199527
[TBL] [Abstract][Full Text] [Related]
8. Requirement of NF-kappaB signalling pathway for modulation of the cholinergic muscarinic M3 receptor expression by INGAP-PP in insulin-producing cells.
Paula FM; Barbosa HC; Carneiro EM; Persaud SJ; Gagliardino JJ; Boschero AC; Souza KL
Eur J Pharmacol; 2010 Sep; 642(1-3):37-46. PubMed ID: 20541544
[TBL] [Abstract][Full Text] [Related]
9. A multi-method evaluation of the effects of Inflammatory cytokines (IL-1β, IFN-γ, TNF-α) on pancreatic β-cells.
Xie K; Xu B; Zhang Y; Chen M; Ji Y; Wang J; Huang Z; Zhou K; Xia Y; Tang W
J Cell Physiol; 2018 Dec; 233(12):9375-9382. PubMed ID: 29923197
[TBL] [Abstract][Full Text] [Related]
10. STAT1-mediated down-regulation of Bcl-2 expression is involved in IFN-γ/TNF-α-induced apoptosis in NIT-1 cells.
Cao ZH; Zheng QY; Li GQ; Hu XB; Feng SL; Xu GL; Zhang KQ
PLoS One; 2015; 10(3):e0120921. PubMed ID: 25811609
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of toxicity by proinflammatory cytokines in a novel human pancreatic beta cell line, 1.1B4.
Vasu S; McClenaghan NH; McCluskey JT; Flatt PR
Biochim Biophys Acta; 2014 Jan; 1840(1):136-45. PubMed ID: 24005237
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway.
Zhang Z; Ding Y; Dai X; Wang J; Li Y
Eur J Pharmacol; 2011 Nov; 670(1):311-6. PubMed ID: 21925162
[TBL] [Abstract][Full Text] [Related]
13. Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: a novel mechanism for pancreatic beta-cell apoptosis.
Gurzov EN; Ortis F; Cunha DA; Gosset G; Li M; Cardozo AK; Eizirik DL
Cell Death Differ; 2009 Nov; 16(11):1539-50. PubMed ID: 19629134
[TBL] [Abstract][Full Text] [Related]
14. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
[TBL] [Abstract][Full Text] [Related]
15. Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction.
Weaver JR; Holman TR; Imai Y; Jadhav A; Kenyon V; Maloney DJ; Nadler JL; Rai G; Simeonov A; Taylor-Fishwick DA
Mol Cell Endocrinol; 2012 Jul; 358(1):88-95. PubMed ID: 22502743
[TBL] [Abstract][Full Text] [Related]
16. Influence of cytokines on Dmt1 iron transporter and ferritin expression in insulin-secreting cells.
Lortz S; Schröter S; Stückemann V; Mehmeti I; Lenzen S
J Mol Endocrinol; 2014 Jun; 52(3):301-10. PubMed ID: 24850829
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.
Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ
J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497
[TBL] [Abstract][Full Text] [Related]
18. Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork.
Kelley MJ; Rose AY; Song K; Chen Y; Bradley JM; Rookhuizen D; Acott TS
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2634-43. PubMed ID: 17525194
[TBL] [Abstract][Full Text] [Related]
19. Phospholipase C-δ(1) regulates interleukin-1β and tumor necrosis factor-α mRNA expression.
Chung E; Jakinovich P; Bae A; Rebecchi M
Exp Cell Res; 2012 Oct; 318(16):1987-93. PubMed ID: 22710061
[TBL] [Abstract][Full Text] [Related]
20. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes.
Lortz S; Tiedge M; Nachtwey T; Karlsen AE; Nerup J; Lenzen S
Diabetes; 2000 Jul; 49(7):1123-30. PubMed ID: 10909968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
